| 查看: 125 | 回复: 1 | |||
| 当前主题已经存档。 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 golkey 的 20 个金币 | |||
golkey铁虫 (正式写手)
|
[交流]
还是得麻烦大家
|
||
|
Limiting residual solvent levels in active substances, excipients and medicinal products The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) has adopted Impurities Guidelines for Residual Solvents which prescribes limits for the content of solvents which may remain in active substances, excipients and medicinal products after processing. This guideline, the text of which is reproduced below, excludes existing marketed products. The European Pharmacopoeia is, however, applying the same principles enshrined in the guideline to existing active substances, excipients and medicinal products whether or not they are the subject of a monograph of the Pharmacopoeia. All substances and products are to be tested for the content of solvents likely to be present in a substance or product. If the use of a Class 1 solvent has been justified and authorised then it is to be limited in the test section of the individual monograph. Normally monographs of the Pharmacopoeia will not include limit tests for individual solvents belonging to Class 2 since the solvents employed may vary from one manufacturer to another. Therefore, the competent authority is to be informed of the solvents employed during the production process. This information is also given in the dossier submitted for a certificate of suitability of the monographs of the European Pharmacopoeia and is mentioned on the certificate. [ Last edited by golkey on 2008-11-3 at 20:33 ] |
» 猜你喜欢
存款400万可以在学校里躺平吗
已经有15人回复
拟解决的关键科学问题还要不要写
已经有6人回复
Materials Today Chemistry审稿周期
已经有6人回复
基金委咋了?2026年的指南还没有出来?
已经有10人回复
基金申报
已经有6人回复
推荐一本书
已经有13人回复
国自然申请面上模板最新2026版出了吗?
已经有17人回复
纳米粒子粒径的测量
已经有8人回复
疑惑?
已经有5人回复
计算机、0854电子信息(085401-058412)调剂
已经有5人回复
golkey
铁虫 (正式写手)
- 应助: 0 (幼儿园)
- 金币: 2177.3
- 散金: 19
- 红花: 8
- 帖子: 816
- 在线: 49.3小时
- 虫号: 509628
- 注册: 2008-02-23
- 性别: MM
- 专业: 塑料
2楼2008-11-03 20:33:26











回复此楼
